Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PARAMET

Financiado

Cerrado

A systematic analysis of parasite metabolism from metabolism to intervention

Parasites exact a devastating toll on health and economic productivity, infecting man and also domestic livestock. Drugs used to combat parasitic diseases are deficient in many ways and new, better drugs are needed to establish s... ver más

31/05/2016

UNIVERSITY OF GLAS...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

UNIVERSITY OF GLASGOW No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 12 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-05-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

12 Participantes

UNIVERSITY OF GLASGOW

0.00€ | Lider

CNRS

N.D. | Participante

GLAXOSMITHKLINE INVESTIGACIO...

N.D. | Participante

UM2

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

A-PARADDISE Anti Parasitic Drug Discovery in Epigenetics 9M€ Cerrado

TRYPOBASE Nucleobase derivatives as drugs against trypanosomal disease... 4M€ Cerrado

KINDRED Kinetoplastid Drug Development strengthening the preclinica... 8M€ Cerrado

GENENET Gene networks to investigate lateral gene transfer in parasi... 183K€ Cerrado

SAF2015-72117-EXP ANALISIS DEL POSIBLE PAPEL DE LA EPIGENETICA EN LA DETERMINA... 54K€ Cerrado

transLEISHion A targeted knockout screen for identification of Leishmania... 195K€ Cerrado

Líder del proyecto

UNIVERSITY OF GLASGOW No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Parasites exact a devastating toll on health and economic productivity, infecting man and also domestic livestock. Drugs used to combat parasitic diseases are deficient in many ways and new, better drugs are needed to establish sustainable means to combat diseases caused by protozoan parasites that include malaria, trypanosomiasis and leishmaniasis in man, and coccidiosis among others in animals. This ITN will train a new generation of European scientists in the requisites of preclinical drug discovery, combining academic excellence in innovation with industrial rigor and thus providing training from an industrial and academic perspective. The programme works on the premise that parasite metabolism offers a multitude of potential targets that can be exploited for drug design. Advances in genomics, transcriptomics, metabolomics and protein chemistry, alongside computational systems biology are integral to the activities of the network. The programme is populated with projects at all levels of the preclinical drug discovery cascade to ensure ESRs and ERs are exposed to requirements and aspects of every step of this process. Therefore aspects of drug design, medicinal chemistry and small molecule screening will also be central to the programme. ESRs will perform research in two different laboratories providing them with multidisciplinary intersectoral training that we consider essential for the development of a highly skilled, knowledgeable new generation of researchers capable of innovation and application of research in a research area of global importance to human health..

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores